Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 16, 2019, 08:00 ET Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

Ambrx Inc. today announced that Bristol-Myers Squibb Company ("BMS") has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics...


Jul 16, 2019, 07:55 ET Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of...


Jul 16, 2019, 07:38 ET Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody

Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the...


Jul 16, 2019, 07:30 ET BiondVax Announces Rights Offering Fully Subscribed at US$20 Million

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is proud to announce today the results of its previously announced rights offering. The Company has...


Jul 16, 2019, 07:30 ET Clinical Trials Market is Projected to Record a 4.5% CAGR Through 2029 - Future Market Insights

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018....


Jul 16, 2019, 07:00 ET Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced it...


Jul 16, 2019, 05:00 ET Human Pancreas on a Chip Opens New Possibilities for Studying Disease

Scientists created human pancreas on a chip that allowed them to identify the possible cause of a frequent and deadly complication of cystic fibrosis ...


Jul 16, 2019, 03:00 ET SurgiMab Advances SGM-101, a Novel Fluorescent Tumor-specific Antibody, Into Pivotal Phase 3 Clinical Trial to Improve Surgical Outcomes in Colorectal Cancer Patients

SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach designed to improve cancer surgery and...


Jul 16, 2019, 02:39 ET Grifols presents additional encouraging Alzheimer's trial results at AAIC

The Grifols Clinical Research team, led by Dr. Antonio Páez, today presented additional results of its AMBAR (Alzheimer Management by Albumin...


Jul 16, 2019, 01:23 ET FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)

Novartis today announced the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) and has granted...


Jul 15, 2019, 16:11 ET Neovasc Participates in Round-Robin Study Evaluating In-Vitro Pulsatile Flow Testing of Prosthetic Heart Valves

Company Joined by Other Industry Leaders as Part of ISO Cardiac Valves Working Group NASDAQ, TSX: NVCN VANCOUVER, July 15, 2019 /PRNewswire/ -...


Jul 15, 2019, 14:42 ET Avances en la búsqueda mundial de marcadores sanguíneos de la enfermedad de Alzheimer y otras demencias

INFORMACIÓN PROCEDENTE DEL CONGRESO INTERNACIONAL DE 2019 DE LA ALZHEIMER'S ASSOCIATION LOS ÁNGELES, 15 de julio de 2019 /PRNewswire/ En el marco del ...


Jul 15, 2019, 13:47 ET Morris Animal Foundation study identifies new fungus linked to freshwater turtle shell disease

Morris Animal Foundation-funded researchers at the University of Illinois identified a new fungus that could be a significant emerging pathogen of...


Jul 15, 2019, 13:08 ET Fortschritte in der weltweiten Erforschung von Blutmarkern für Alzheimer und andere Demenzerkrankungen

Bei der Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles wurde von signifikanten Fortschritten in der weltweiten...


Jul 15, 2019, 12:30 ET Progrès dans la recherche mondiale de marqueurs sanguins de la maladie d'Alzheimer et d'autres formes de démence

Des progrès importants dans la recherche mondiale de technologies de test sanguin pour la maladie d'Alzheimer et d'autres formes de démence ont été...


Jul 15, 2019, 12:30 ET Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at the Alzheimer's...


Jul 15, 2019, 11:00 ET Surprising Differences Found In How Sleep Medications Increase Dementia Risk For Some, Protect Others

New research reported at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles evaluates drug and non-drug treatments to...


Jul 15, 2019, 10:00 ET FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance ...


Jul 15, 2019, 09:02 ET Endotronix incluye a un primer paciente en el ensayo SIRONA II con la vista puesta en la obtención del marcado CE

Endotronix, Inc., empresa de tecnologías médico-sanitarias digitales especializada en la mejora del tratamiento de la insuficiencia cardíaca, ha...


Jul 15, 2019, 09:02 ET Endotronix nimmt ersten Patienten in die „SIRONA II"-Studie zum Erlangen des CE-Zeichens auf

Endotronix, Inc., ein Unternehmen für digitale Gesundheitstechnologie und Medizintechnologie, das sich für Fortschritte in der Behandlung von...


Jul 15, 2019, 09:02 ET Endotronix recrute un premier patient pour l'essai de SIRONA II pour le marquage CE

Endotronix, Inc., une société de technologie numérique médicale et de la santé ayant pour mission d'améliorer le traitement de l'insuffisance...


Jul 15, 2019, 09:02 ET Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment...


Jul 15, 2019, 08:30 ET Neurotrope Concludes Data Collection in Confirmatory Phase 2 Clinical Trial of Moderately Severe to Severe Alzheimer's Disease

Neurotrope Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including...


Jul 15, 2019, 08:30 ET Seqirus is First-to-Market with U.S. 2019/20 Influenza Vaccines

Seqirus is first to begin shipping its portfolio of seasonal influenza vaccines for the upcoming 2019/20 U.S. influenza season Seqirus plans to...


Jul 15, 2019, 08:00 ET New study of ultrasound enhancing agents in echocardiography reaffirms safety profile of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business,...